Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Neoplasms × Sunitinib × Clear all

Phase

Status

Completed 22 Terminated 6 Unknown 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma, Renal Cell 6 Gastrointestinal Stromal Tumors 3 Urologic Neoplasms 2 Carcinoma 2 Uveal Melanoma 1 Sarcoma 1 Prostatic Neoplasms 1 Neoplasms by Site 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lymphoma 1 Kidney Neoplasms 1 Kidney Diseases 1 Advanced Renal Cancer 1 Advanced Rare Tumours 1

Interventions

pembrolizumab 27 Cyclophosphamide 17 Nivolumab 16 fludarabine 8 Surveys and Questionnaires 8 Paclitaxel 8 Exercise 8 Doxorubicin 8 Carboplatin 8 Bevacizumab 8 budigalimab 7 atezolizumab 7 Radiotherapy 7 Fluorouracil 7 Docetaxel 7 Dexamethasone 7 Blood Specimen Collection 7 venetoclax 6 lenvatinib 6 cabozantinib 6 Rituximab 6 Prednisone 6 Pemetrexed 6 Oxaliplatin 6 Gemcitabine 6 fludarabine phosphate 5 durvalumab 5 avelumab 5 Vincristine 5 Leucovorin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03768063 2026-01-29

IMbrella B

Hoffmann-La Roche

Phase 3 Active not recruiting

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡